MNKD Competitors
MannKind Corporation
$3.02
-$0.03(-0.98%)
24
Overall
20
Value
18
Tech
34
Quality
Market Cap
$980.71M
Volume
7.93M
52W Range
$2.23 - $6.51
Target Price
$7.84
MNKD competitors: HALO, NVO, MRK, LLY, NKTR. MannKind Corporation is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
MNKD Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| HALO Halozyme Therapeutics, Inc. | $116.82 | $13.26B | $8.25 | - | 62 |
| NVO Novo Nordisk A/S | $38.12 | $168.79B | $3.53 | 4.86% | 47 |
| MRK Merck & Co., Inc. | $147.37 | $350.29B | $2.66 | 2.31% | 67 |
| LLY Eli Lilly and Company | $1208.74 | $1.14T | $36.19 | 0.55% | 60 |
| NKTR Nektar Therapeutics | $36.89 | $1.26B | $-8.16 | - | 30 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MNKD | $3.02 | -1.0% | 7.93M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |